Eggshell Weekly Report 0604: 105 Companies Break Through in Medical AI, 56 Healthcare Firms Queue for IPO
VCBeat Headlines
From May 17 to 18, the “2017 China Primary Healthcare Innovation Practice Forum” was grandly held in Chengdu. During the roundtable discussion on the afternoon of May 17, Gao Yi (Moderator), Partner at Yuanyi Capital; Yang Sa, Chairman of Xinkang Medical; Wang Weixing, Investment Director at Huafang Pharmaceutical; Fan Shaofei, Chairman of Ping An Wanjia Medical; He Haiyang, Chairman of Johnson Medical; Jiang Qiang, Chairman of Mingyi Zhonghe; and Yu Haobo, Chairman of Lanka Health, jointly shared their insights on “Exploring the Path to Chain Development for Primary Healthcare Institutions.” | ||
Primary Healthcare | 2017-05-29 | |
Compared to other sectors, the barriers to leveraging AI technology to revolutionize healthcare are significantly higher. Even by riding the wave of AI hype, enthusiasm wanes quickly, as in the medical field, a single algorithmic error can often mean the difference between life and death. How should we approach medical AI, and where are its current applications concentrated? To address these questions, VCBeat (WeChat: vcbeat) has curated and translated the latest in-depth article from mobihealthnews for our readers. | ||
Artificial Intelligence | 2017-05-30 | |
Baidu Returns to Its Tech Roots: The “B” vs. “AT” Battle in Healthcare and AI Has Just Begun | ||
On May 27, 2017, in Wuzhen, Ke Jie rose from his seat after completing the 126th move as White. Confronted with the insurmountable gap in strength against AlphaGo, he broke down in tears on the spot. In fact, from that moment onward, the contest between humans and AlphaGo in the game of Go was effectively over, even though this globally watched ultimate “human-machine showdown” ended in a decisive 0–3 defeat for the human side. In recent years, the rapid development of artificial intelligence has left its human creators increasingly apprehensive. | ||
Medicine and Pharmaceuticals | 2017-05-31 | |
Among the 56 healthcare-related companies currently under review, 7 have had their applications accepted, 31 are in the feedback stage, 8 are in the pre-disclosure update stage, 5 have passed the Issuance Examination Committee review, 1 has appeared before the Committee but had its decision deferred, and 4 are under suspended review. (Update as of May 24: Shenzhen BGI Genomics has passed the Issuance Examination Committee review.) VCBeat has compiled a list detailing the review status of all companies in the queue, their respective sub-sectors, and specific information on companies whose reviews have been terminated. | ||
Biotechnology | 2017-06-01 | |
These Four Types of Tools May Help Retail Pharmacies Resolve Their “Internet+” Dilemmas | ||
VCBeat conducted a preliminary scan of existing “Internet + Pharmacy” projects in the market, categorizing them along the dimensions of procurement, management, services, and marketing. By detailing the various ways these Internet-enabled pharmacies operate at a granular level, VCBeat aims to identify the industry’s key growth opportunities. | ||
Primary Healthcare | 2017-06-02 | |
Arterial Viewpoint
Vice President of Xiuzheng Health GroupZhang Xuehai
During the presentation, Zhang Xuehai introduced the Health Pavilion System from four perspectives. He stated that the Xiuzheng Internet+ Remote Smart Medical Health Pavilion System is a domestically produced, independent, secure, and controllable internet medical health big data platform. It is built upon Traditional Chinese Medicine (TCM) workstations, leverages the achievements of the National Health Informatics “46312” Project, and adheres to the national health information standard system and security assurance framework.
Chairman of Hailiying Yu Hai
Regarding telemedicine models, Yu Hai personally disagrees with the B2C approach. He believes that, first, specialists typically have limited time; direct communication with patients may lead to unclear expression and low efficiency, whereas communication between specialists and healthcare professionals at primary care institutions yields better results. Second, there are clear liability relationships in the two-way referral systems of physical medical institutions, making them more reliable than pure online telemedicine. Additionally, face-to-face interaction between doctors and patients is crucial in medical practice, an area where online B2C telemedicine falls short. In Hailiying’s system, patients interact directly with primary care physicians.
Financial Support for Industrial Upgrading: "Deep Vertical" Strategy in Primary Healthcare
General Manager, BiHai'er Industrial Finance Zhang Lei
The socialization of medical resources requires that most physicians become independent, autonomous practitioners. Only in this way can multi-site practice be truly realized, and medical talent be utilized effectively. As many doctors transition from the public system to the private sector as independent individuals—either by starting their own ventures or establishing physician groups—they often possess only clinical expertise, while lacking strengths in marketing, market development, and management. This situation has given rise to new opportunities.
Capital Dynamics
This week, in the medical field both domestically and internationally, there are a total of7Financing event.
Event Preview
Industry Dynamics
Hot Topics
“Internet Queen” Releases “Internet Trends Report,” Featuring Extensive Discussion on Digital Health | |||||
On May 31 local time, Mary Meeker released the 2017 “Internet Trends Report,” devoting a substantial 31 pages for the first time to arguing that “digital health has reached a turning point.” The volume and diversity of data from wearable devices and mobile apps are increasing significantly, while the amount of data in hospital electronic medical record systems is also growing rapidly. Meanwhile, the variety of medical laboratory tests has expanded and their accessibility has improved, and contemporary genetic testing technologies are exerting diverse impacts. | |||||
Report | |||||
Tongrentang Invests 1 Billion to Enter the Elderly Care Sector | |||||
Beijing Tongrentang, in partnership with investors such as Zhongyuan Expressway and Sun Paper, has jointly established the Beijing Tongrentang Elderly Care Industry Fund, with a scale of approximately RMB 1 billion. Concurrently, the Tongrentang Beijing Health and Elderly Care Project has been launched, marking the official implementation of Beijing Tongrentang’s national strategy for health and elderly care, a time-honored brand with a century-long heritage. | |||||
Elderly Care | |||||
China’s First Transcatheter Heart Valve Hits the Market | |||||
On May 31, the Venus A-Valve, China’s first transcatheter heart valve developed by Hangzhou Qiming Medical Device Co., Ltd., was officially launched, marking the formal entry of transcatheter aortic valve implantation (TAVI) in China into the commercialization phase. As the incubator for this project, Denovo Group (“Denovo”) has also drawn industry attention for its strengths in investment, incubation, and operations within the innovative medical device sector. | |||||
Instruments | |||||
National Children's Medical Center Officially Inaugurated | |||||
Yesterday, on International Children's Day, the National Center for Children’s Health was officially inaugurated in both Beijing and Shanghai. The National Center for Children’s Health (Beijing) will be led by Beijing Children’s Hospital, while the Shanghai branch will be jointly hosted by the Children’s Hospital of Fudan University and the Shanghai Children’s Medical Center affiliated with Shanghai Jiao Tong University School of Medicine, together constituting the National Center for Children’s Health. | |||||
Pediatrics | |||||
Cirina, Founded by Professor Dennis Lo, Merges with Global Liquid Biopsy Newcomer GRAIL | |||||
Global liquid biopsy upstart GRAIL announces merger with Cirina, founded by Professor Dennis Lo, the pioneer of non-invasive prenatal testing (NIPT), to focus on early cancer detection. Professor Lo has been appointed as Scientific Co-Founder of the merged entity and will join GRAIL’s Scientific Advisory Board. | |||||
Medical Aesthetics | |||||
Listed Company
Humanwell Healthcare | Investment | ||
with1.2$100 Million Acquisition of Wuhan Jissbon Hygiene Products Co., Ltd.54%'s equity. The capital contribution shall not exceed1.2USD 100 million to establish a wholly-owned subsidiary in SingaporeRFSWInvestment PTE. LTD., and then byRFSW Investment PTE. LTD.Capital contribution not exceeding1.2 Establish a wholly-owned subsidiary in Singapore with hundreds of millions of US dollars.RFSW Management PTE. LTD., for the purpose of investing in and managing overseas pharmaceutical and healthcare industries. WithCITIC Capital Cupid Investment LimitedIn total4 $100 million co-investment for acquisitionAnsell Ltd.Subsidiaries involved in the global (excluding China) sexual health business of both genders6Subsidiary100%equity. | |||
Changshan Pharmaceutical | Self-built | ||
5Month31Rishan Pharmaceutical Industry has announced that the company plans to advance its support for the construction of the Xiong’an New Area through three key initiatives: actively deploying medical services by establishing a cancer hospital and hemodialysis centers in the Xiong’an New Area, thereby assuming medical service functions transferred from Beijing; setting up a pharmaceutical research institute in the Xiong’an New Area to further strengthen collaboration with domestic and international drug R&D institutions, attract high-end R&D talent, and enhance R&D capabilities; and leveraging mechanisms such as the establishment of industrial funds to integrate pharmaceutical manufacturing enterprises in the Xiong’an New Area and its surrounding regions through mergers, acquisitions, and restructuring. | |||
Seeking Medical Care160 | Name Change | ||
6Month1[Day] News: Ningyuan Technology, a company listed on the New Third Board, operates the mobile healthcare platform “Jiuyi”160”Recently officially announced its name change to “Health160”, while simultaneously launching a brand-newLOGO, and announced a comprehensive upgrade to the company's strategy. | |||
Jianzhijia | Listing | ||
Recently, Yunnan Jianzhijia Health Chain Stores Co., Ltd.(hereinafter referred to as "Jianzhijia") Disclosed its prospectus on the CSRC website, planning to list on the Shanghai Stock Exchange, with an initial public offering of no more than132510,000 shares, proposed fund raising5.09hundred million yuan, which will be invested in three major projects: the construction of new chain stores, the upgrade of information systems, and the development of an omni-channel marketing platform. | |||
Pien Tze Huang | Product | ||
5Month27On [date], Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. issued an announcement stating that, due to factors such as rising costs of major raw materials and labor for its Pien Tze Huang products, the company has decided to adjust the market retail price of its flagship product, Pien Tze Huang, effective from the date of the announcement.500Yuan/Titration up to530Yuan/per tablet, the supply price will be adjusted upward accordingly. | |||
Frontiers of Technology
Ultrasound | Application Areas | Bone Setting |
Dan Gazit and Gadi from Cedars-Sinai Medical Center in the United States Professor Pelled’s team used ultrasound to deliver specific genes into patients’ own stem cells, prompting the stem cells to differentiate into osteoblasts and enabling spontaneous healing of nonunion fractures in patients with bone nonunions. | ||
Innovative Drugs for Lung Cancer | Application Areas | Respiration |
Novartis announced that the U.S. FDA has approved an expanded indication for Zykadia (ceritinib) as a first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are confirmed to be anaplastic lymphoma kinase (ALK)-positive by an FDA-approved test. Zykadia First granted accelerated approval in 2014 for the treatment of ALK-positive metastatic NSCLC, [for patients whose] disease progressed on or who were intolerant to crizotinib Intolerance. | ||
Skin Repair Gun | Application Areas | Skin Lesion |
A team of scientists at RenovaCare has developed a novel medical device for treating burns—the SkinGun—which employs a “skin cell spray” approach to regenerate skin! It directly sprays an aqueous solution containing stem cells onto the patient’s skin to promote autonomous skin repair. | ||
Intensity-Modulated Precision Radiation Therapy Planning System | Application Areas | Tumor |
The Institute of Nuclear Energy Safety Technology, Chinese Academy of Sciences, announced that its independently developed “Intensity-Modulated Precision Radiotherapy Planning System” (Qilin Knife) has recently passed national testing. This marks the first domestically produced intensity-modulated radiotherapy planning system to pass testing under the national standard since its implementation. | ||
Antioxidants | Application Areas | Skin Aging |
A new study from the University of Maryland (UMD) indicates that methylene blue, a commonly used, inexpensive, and safe antioxidant, can slow skin aging in humans. Researchers found that methylene blue slowed or reversed several signs of aging when tested on cultured human skin cells and simulated skin tissues. | ||
Innovative Drugs for Lung Cancer Diagnosis | Application Areas | Lung Cancer |
Roche (Roche) The company announced the United StatesFDAApprovalVENTANA ALK（D5F3）CDxAssay Kit for IdentificationALKPositive non-small cell lung cancer (NSCLC) companion diagnostics for patients to determine eligibility for Novartis (Novartis) Drug ProductsZYKADIA（ceritinib) treatment. Currently,VENTANA ALK（D5F3) assay is the onlyFDAApproved asZYKADIACompanion Diagnostic Immunohistochemistry (IHC) detection method. | ||
Gut Microbiota | Application Areas | Brain Diseases |
Recently, a study published in Nature found that gut bacteria can influence the structure of cerebral blood vessels and may cause malformations, leading to stroke or epilepsy. | ||
In-Depth Report
Report Name | Publisher | Content Introduction |
2017 Digital Health Outlook | Accenture | The report warns that as digitalization permeates various industries, healthcare should return to its core mission. It proposes the concept of “technology for people” and outlines five major trends in the digital health sector in 2017. |
Weekly report details can be accessed in the VCBeat knowledge base!
